This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

5 Stocks Insiders Are Snapping Up

Valeant Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Insiders are also buying up a large amount of stock in is Valeant Pharmaceuticals (VRX), a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Insiders are paying up here and buying into strength since shares are up big in 2011 by over 60%.

Valeant Pharmaceuticals has a market cap of $14.40 billion and an enterprise value of $19.31 billion. This stock trades at a premium valuation, with a trailing price-to-earnings of 199.87. This is far from a cash-rich company, since the total cash position on its balance sheet is $257.53 million and its total debt is a whopping $5.23 billion.

The CFO just bought 32,500 shares, or about $1.5 million worth of stock, at $46.05 to $46.26 per share. This same CFO also just bought 11,000 shares, or $515,020 worth of stock, at $46.82 per share.

From a technical standpoint, VRX is currently trading above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending strong since it hit a recent low of $32.05 in October. During that uptrend, shares of VRX have been consistently making higher highs and higher lows, which is bullish price action. Now traders should watch for a big breakout to trigger if VRX can move above some near-term overhead resistance levels.

If you're interested in VRX from the long side, then I would look add some stock once it breaks out above $47.58 on high volume. Look for volume that's tracking in close to or above its three-month average action of 2.45 million shares on any future breakout. I would simply use a mental stop a few percentage points below the breakout level if you get long off strength. Target a big run on this stock back toward $56 to $57 a share if we get that high-volume breakout in the coming days or weeks.

Valeant is one of the top holdings of Julian Robertson's Tiger Management, and it comprises 5.7% of Blue Ridge Capital's portfolio.

4 of 6

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,113.54 +61.81 0.36%
S&P 500 1,983.53 +9.90 0.50%
NASDAQ 4,456.0160 +31.3120 0.71%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs